RNActive®-derived cancer vaccine
Laufzeit: 01.01.2009 - 31.12.2010
imported
Kurzfassung
Safety and efficacy phase I /IIa trial of on RNActive- derived cancer vaccine in stage IIIB/IV NSCLC
Laufzeit: 01.01.2009 - 31.12.2010
Safety and efficacy phase I /IIa trial of on RNActive- derived cancer vaccine in stage IIIB/IV NSCLC